Chen · International journal of environmental research and public health 2023 · randomized controlled trial · n=60

Transcutaneous Auricular Vagus Nerve Stimulation Facilitates Cortical Arousal and Alertness.

Cited 38 times in the scientific literature.

Level 2 - randomized trial

Individual randomized controlled trial

PubMed 36674156 · doi:10.3390/ijerph20021402 · record verified 2026-08-29

What was done

Sixty subjects were randomly assigned to receive either 20 minutes of transcutaneous auricular vagus nerve stimulation (taVNS) or a control intervention consisting of 30 seconds of taVNS. Effects on cortical arousal and alertness were assessed behaviorally using a cue-target pattern task and neurologically through resting-state electroencephalogram (EEG) power and microstate analyses during an eyes-closed condition.

What was found

The abstract reports effect directions without numerical data, test statistics, or effect sizes. Relative to control, taVNS facilitated reaction times for targets requiring right-hand responses and attenuated high-frequency alpha oscillations during eyes-closed resting state. The reduction in high-frequency alpha power positively correlated with reaction time improvements. In addition, taVNS reduced the mean duration of EEG microstate C.

Why it matters

The findings offer preliminary evidence that noninvasive auricular vagus nerve stimulation can modulate electrophysiological markers of cortical arousal and improve response speed in an alertness task.

Limits

The abstract lacks exact numbers, effect sizes, p-values, and confidence intervals. The sample size is modest (n = 60), only immediate post-stimulation outcomes were evaluated, the behavioral speedup was restricted to right-hand responses, and baseline participant demographics are unspecified.

Cited by